SIGA Technologies Up More Than 12% Following Positive Earnings

Dow Jones2022-08-05

By Connor Hart

Shares of SIGA Technologies Inc. rose more than 12% after the company on Friday posted increased profit and revenue in its second quarter, driven by monkeypox-fueled pharmaceutical demand.

The company's most recent quarterly earnings were bolstered by sales for an antiviral medication used to treat orthopoxviruses such as smallpox and monkeypox.

The New York-based pharmaceutical company said net income rose to $2 million, or 3 cents a share, from $169,000, or flat on a per-share basis, in the previous year.

Sales for the quarter ended June 30 grew to $16.7 million, up from $8.7 million in the year-ago quarter.

Shares of the company closed Thursday at $19.47 before hitting a 52-week high of $23.03 on Friday. The company's share price has nearly tripled so far this year and is up more than 250% in the last 52 weeks.

Write to Connor Hart at connor.hart@wsj.com

$(END)$ Dow Jones Newswires

August 05, 2022 11:49 ET (15:49 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2257197758?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-05 23:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2257197758","market":"us","top_or_hot":-1,"title":"SIGA Technologies Up More Than 12% Following Positive Earnings","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/SIGA\">SIGA Technologies Inc</a>. rose more than 12% after the company on Friday posted increased profit and revenue in its second quarter, driven by monkeypox-fueled pharmaceutical demand. \n</p>\n<p>\n  The company's most recent quarterly earnings were bolstered by sales for an antiviral medication used to treat orthopoxviruses such as smallpox and monkeypox. \n</p>\n<p>\n  The New York-based pharmaceutical company said net income rose to $2 million, or 3 cents a share, from $169,000, or flat on a per-share basis, in the previous year. \n</p>\n<p>\n  Sales for the quarter ended June 30 grew to $16.7 million, up from $8.7 million in the year-ago quarter. \n</p>\n<p>\n  Shares of the company closed Thursday at $19.47 before hitting a 52-week high of $23.03 on Friday. The company's share price has nearly tripled so far this year and is up more than 250% in the last 52 weeks. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 05, 2022 11:49 ET (15:49 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIGA Technologies Up More Than 12% Following Positive Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIGA Technologies Up More Than 12% Following Positive Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-05 23:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Connor Hart \n\n\n \n\n\n  Shares of SIGA Technologies Inc. rose more than 12% after the company on Friday posted increased profit and revenue in its second quarter, driven by monkeypox-fueled ...</p>\n\n<a href=\"http://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SIGA","symbol_name":"SIGA Technologies Inc","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2257197758","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2257197758","pubTimestamp":1659714540,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Connor Hart \n\n\n \n\n\n  Shares of SIGA Technologies Inc. rose more than 12% after the company on Fri","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SIGA":"SIGA Technologies Inc"},"translate_title":"SIGA Technologies上涨超过12%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIGA":1},"content_text":"By Connor Hart \n\n\n \n\n\n  Shares of SIGA Technologies Inc. rose more than 12% after the company on Friday posted increased profit and revenue in its second quarter, driven by monkeypox-fueled pharmaceutical demand. \n\n\n  The company's most recent quarterly earnings were bolstered by sales for an antiviral medication used to treat orthopoxviruses such as smallpox and monkeypox. \n\n\n  The New York-based pharmaceutical company said net income rose to $2 million, or 3 cents a share, from $169,000, or flat on a per-share basis, in the previous year. \n\n\n  Sales for the quarter ended June 30 grew to $16.7 million, up from $8.7 million in the year-ago quarter. \n\n\n  Shares of the company closed Thursday at $19.47 before hitting a 52-week high of $23.03 on Friday. The company's share price has nearly tripled so far this year and is up more than 250% in the last 52 weeks. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  August 05, 2022 11:49 ET (15:49 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2257197758"}